Assessing Chemotherapy-Induced Nausea and Vomiting in Breast Cancer Patients in Malaysia: Insights into Quality of Life and Genetic Influences
Middle Eastern Cancer and Oncology Journal · 2025
DOI: 10.61706/mecoj16004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Middle Eastern Cancer and Oncology Journal, 2025. Verfasst von Bassam Abdul Rasool Hassan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Malaysia faces a persistent public health challenge in the form of breast cancer, which affects approximately one in twenty women and accounts for a significant proportion of cancer-related mortality across diverse ethnic groups and age demographics. Despite the advancements in cancer therapeutics, the side effects of chemotherapy, particularly nausea and vomiting, continue to profoundly impact the quality of life of breast cancer patients.
Objective
The objective of this scoping review is to explore the prevalence, management practices, and factors contributing to chemotherapy-induced nausea and vomiting (CINV) among breast cancer patients in Malaysia, with a focus on its implications for patient care and treatment outcomes. Methodology: A systematic search of PubMed, Scopus, and local Malaysian journals was conducted to identify relevant studies. The articles identified were then screened and selected based on predefined inclusion criteria. Key themes related to CINV prevalence, management strategies, and patient outcomes were extracted and synthesized.
Findings
The review's findings underscore the prominence of nausea and vomiting as major side effects of breast cancer chemotherapy, leading to complications such as poor treatment adherence and suboptimal response rates. The analysis indicates that current management practices within Malaysia's healthcare system are inadequate in alleviating the severity of CINV or enhancing patients' quality of life. Furthermore, the multiethnic composition of the Malaysian population introduces genetic variations that influence drug metabolism, resulting in disparities in treatment efficacy and tolerability.
Conclusion
The findings underscore the critical impact of CINV on the quality of life of breast cancer patients, highlighting the necessity for a re-evaluation of existing treatment guidelines and the development of customized strategies tailored to the Malaysian population. Enhancing CINV prevention and management practices has the potential to markedly improve patient health outcomes and treatment success.
Zitieren
APA
Hassan, B. A. R. (2025). Assessing Chemotherapy-Induced Nausea and Vomiting in Breast Cancer Patients in Malaysia: Insights into Quality of Life and Genetic Influences. Middle Eastern Cancer and Oncology Journal. https://doi.org/10.61706/mecoj16004
Vancouver
Hassan BAR. Assessing Chemotherapy-Induced Nausea and Vomiting in Breast Cancer Patients in Malaysia: Insights into Quality of Life and Genetic Influences. Middle Eastern Cancer and Oncology Journal. 2025. doi:10.61706/mecoj16004
BibTeX
@article{Hassan2025,
author = {Hassan, Bassam Abdul Rasool},
title = {Assessing Chemotherapy-Induced Nausea and Vomiting in Breast Cancer Patients in Malaysia: Insights into Quality of Life and Genetic Influences},
journal = {Middle Eastern Cancer and Oncology Journal},
year = {2025},
doi = {10.61706/mecoj16004}
}
EUVIMED